Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders

Brief summary (registry, in English)

People with psychotic disorders are at a higher risk of premature death than the general population. Adverse lifestyle factors contribute to this reduced life expectancy; such factors may include high consumption of tobacco and other substances, physical inactivity, and obesity. These lifestyle factors increase the risk of type 2 diabetes, cardiovascular disease, and cancer-conditions known as non-communicable diseases (NCDs). Primary care offers an evidence-based and cost-effective method known as "Targeted Health Dialogues" (Riktade hälsosamtal), aimed at individuals in their forties to motivate lifestyle changes. Previous studies indicate that people with psychotic disorders-particularly those with lower levels of social functioning, comorbidities, or concerns about stigma-frequently miss appointments at primary care centers, whereas in outpatient psychiatric care, they may establish long-term therapeutic relationships with specialist nurses. There is thus a need to evaluate the feasibility of using this evidence-based, nurse-led method-Targeted Health Dialogues-to support healthy lifestyle changes and reduce NCD risk among people with psychotic disorders receiving outpatient psychiatric care. The findings of this study will provide a basis for designing nurse-led lifestyle support interventions for individuals with psychotic disorders.

What you commit to

• Study type: Interventional
• Planned participants: 60
• From 1 Oct 2026 to the primary completion date, 1 Dec 2030
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov